Invention Grant
- Patent Title: Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
-
Application No.: US16148601Application Date: 2018-10-01
-
Publication No.: US10751382B2Publication Date: 2020-08-25
- Inventor: Neil R. Cashman
- Applicant: The University of British Columbia , PROMIS NEUROSCIENCES, INC
- Applicant Address: CA Vancouver
- Assignee: The University of British Columbia
- Current Assignee: The University of British Columbia
- Current Assignee Address: CA Vancouver
- Agency: Bereskin & Parr LLP
- Agent Carmela De Luca
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; A61K49/00 ; A61K49/16 ; C07K16/00 ; C12P21/08 ; G01N33/53 ; A61K38/07 ; A61K38/12 ; A61K39/385 ; A61K47/64 ; C07K14/47 ; C07K5/117 ; C07K7/06 ; C07K7/64 ; C12N5/16 ; G01N33/68 ; A61P25/28 ; C07K16/18 ; C07K5/083 ; C07K5/087 ; C07K5/09 ; C07K5/093 ; C07K5/097 ; C07K5/113 ; A61K51/08 ; A61K49/18 ; A61K45/00 ; A61K38/00 ; A61K38/05 ; A61K51/10 ; A61K47/68 ; A61K38/08 ; A61K39/39 ; A61K45/06 ; A61K47/69 ; A61L31/10 ; A61L27/34 ; A61L29/16 ; A61L31/16 ; A61L29/08 ; A61L27/22 ; G01N33/50 ; C07K5/103 ; C07K14/435 ; C12N5/10 ; C07K7/08
Abstract:
The disclosure pertains to methods of treating or preventing a disease or condition associated with and/or induced by soluble A-beta oligomer such as Alzheimer's disease by administering to a subject in need thereof conformation specific and/or selective antibodies or binding fragments thereof and related products.
Public/Granted literature
- US20190151401A1 Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions Public/Granted day:2019-05-23
Information query
